Trial Profile
A randomized, double-blind, placebo controlled study to analyse the relationship of QT interval and exposure to Nitazoxanide, a prospective candidate for influenza antiviral therapy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary) ; Moxifloxacin
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 07 Dec 2015 New trial record